Determination of the Prevalence of Aspirin and Clopidogrel Resistances in Patients with Coronary Artery Disease by using Various Platelet-function Tests

키워드

참고문헌 (40)

1. Bertrand ME, "Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: the clopidogrel aspirin stent international cooperative study (CLASSICS)", Circulation, 102, pp.624~629 (2000)
2. Mehta SR, "Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study", Lancet, 358, pp.527~533 (2001)
3. Steinhubl SR, "Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial", JAMA, 288, pp.2411~2420 (2002)
4. Bhatt DL, "Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting", J Am Coll Cardiol, 39, pp.9~14 (2002)
5. Gurbel PA, "Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity", Circulation, 107, pp.2908~2913 (2003)
6. Matetzky S, "Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction", Circulation, 109, pp.3171~3175 (2004)
7. Buonamici P, "Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis", J Am Coll Cardiol, 49, pp.2312~2317 (2007)
8. Gurbel PA, "Platelet reactivity in patients and recurrent events post-stenting:results of the PREPARE POST-STENTING Study", J Am Coll Cardiol, 46, pp.1820~1826 (2005)
9. Cuisset T, "High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome", J Thromb Haemost, 4, pp.542~549 (2006)
10. Lordkipanidzé M, "Aspirin resistance: truth or dare", Pharmacol Ther, 112, pp.733~743 (2006)
11. Sharma RK, "Aspirin and clopidogrel hyporesponsiveness and nonresponsiveness in patients with coronary artery stenting", Vasc Health Risk Manag, 5, pp.965~972 (2009)
12. Azam SM, "Variable platelet responsiveness to aspirin and clopidogrel: role of platelet function and genetic polymorphism testing", Transl Res, 154, pp.309~313 (2009)
13. Michelson AD, "Platelet function testing in cardiovascular diseases", Circulation, 110, pp.e489~e493 (2004)
14. Harrison P, "Progress in the assessment of platelet function", Br J Haematol, 111, pp.733~744 (2000)
15. Cardinal DC, "The electronic aggregometer: a novel device for assessing platelet behavior in blood", J Pharmacol Methods, 3, pp.135~158 (1980)
16. Schwarz UR, "Flow cytometry analysis of intracellular VASP phosphorylation for the assessment of activating and inhibitory signal transduction pathways in human platelets--definition and detection of ticlopidine", clopidogrel effects, 1999, pp.82, 1145~1152
17. Dussaillant NG, "Conte LG, Cuneo VM. Frequency and characteristics of aspirin resistance in Chilean cardiovascular patients", Rev Med Chil, 133, pp.409~417 (2005)
18. Gum PA, "Profile and prevalence of aspirin resistance in patients with cardiovascular disease", Am J Cardiol, 88, pp.230~235 (2001)
19. Harrison P, "Screening for aspirin responsiveness after transient ischemic attack and stroke: comparison of 2 point-of-care platelet function tests with optical aggregometry", Stroke, 36, pp.1001~1005 (2005)
20. Bliden KP, "Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate?", J Am Coll Cardiol, 49, pp.657~666 (2007)
21. Coleman JL, "Determination of individual response to aspirin therapy using the Accumetrics Ultegra RPFAASA system", Point Care, 3, pp.77~82 (2004)
22. Malinin A, "Assessing aspirin responsiveness in subjects with multiple risk factors for vascular disease with a rapid platelet function analyzer", Blood Coagul Fibrinolysis, 15, pp.295~301 (2004)
23. 이경훈, "The Significance of Clopidogrel Low-Responsiveness on Stent Thrombosis and Cardiac Death Assessed by the Verifynow P2Y12 Assay in Patients With Acute Coronary Syndrome Within 6 Months After Drug-Eluting Stent Implantation", Korean Circulation Journal, 39(12), pp.512~518 (2009), 대한심장학회
24. Barragan P, "Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation", Catheter Cardiovasc Interv, 59, pp.295~302 (2003)
25. Nicholson NS, "Assessment of platelet function assays", Am Heart J, 135, pp.S170~S178 (1998)
26. Michelson AD, "Current options in platelet function testing", Am J Cardiol, 98, pp.4N~10N (2006)
27. Mueller T, "Utility of whole blood impedance aggregometry for the assessment of clopidogrel action using the novel Multiplate analyzer--comparison with two flow cytometric methods", Thromb Res, 121, pp.249~258 (2007)
28. Wang TH, "Aspirin and clopidogrel resistance:an emerging clinical entity", Eur Heart J, 27, pp.647~654 (2006)
29. Lordkipanidzé M, "A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease", Eur Heart J, 28, pp.1702~1708 (2007)
30. Gurbel PA, "Clopidogrel resistance?", Thromb Res, 120, pp.311~321 (2007)
31. Angiolillo DJ, "Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting", Thromb Res, 115, pp.101~108 (2005)
32. Marcucci R, "Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events", Am J Cardiol, 98, pp.1156~1159 (2006)
33. Müller I, "Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement", Thromb Haemost, 89, pp.783~787 (2003)
34. Collet JP, "Platelet function testing and implications for clinical practice", J Cardiovasc Pharmacol Ther, 14, pp.157~169 (2009)
35. Grotemeyer KH, "Two-year followup of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients", Thromb Res, 71, pp.397~403 (1993)
36. Ajzenberg N, "Enhanced shear-induced platelet aggregation in patients who experience subacute stent thrombosis: a case-control study", J Am Coll Cardiol, 45, pp.1753~1756 (2005)
37. Gurbel PA, "Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study", J Am Coll Cardiol, 46, pp.1827~1832 (2005)
38. Motovska Z, "Optimal pretreatment timing for high load dosing (600 mg) of clopidogrel before planned percutaneous coronary intervention for maximal antiplatelet effectiveness", ~ (2009), Int J Cardiol. Forthcoming
39. Price MJ, "Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation", Eur Heart J, 29, pp.992~1000 (2008)
40. Frere C, "ADP-induced platelet aggregation and platelet reactivity index VASP are good predictive markers for clinical outcomes in non-ST elevation acute coronary syndrome", Thromb Haemost, 98, pp.838~843 (2007)

관련 논문AI추천